Latest Winding Up News

The Supreme Court of Western Australia has approved the scheme of arrangement under which Genesis Minerals will acquire Magnetic Resources, triggering trading suspension and setting a clear timetable for share transfers and new listings.

InFocus Group Holdings is streamlining its software development operations by divesting Prodigy9 and consolidating under Onify, aiming for immediate cost savings and a leaner, AI-native delivery model.

Monadelphous has landed a $380 million contract to build and install gas turbine units at CS Energy’s Brigalow Peaking Power Plant in Queensland, marking a significant step in the company’s energy infrastructure pipeline.

Megado Minerals is poised to kick off its maiden drilling campaign at the Iberian Copper Project in northern Spain, targeting historic copper oxide deposits and exploring for deeper sulphide mineralisation with new geophysical surveys underway.

Bubs Australia expects FY26 revenue between $105 million and $115 million, with underlying EBITDA forecast at $4 million to $8 million despite external challenges including regulatory delays and increased air freight costs.

Stride Property Group posted a 44% jump in FY26 profit after tax to $31.3 million, driven by strategic portfolio moves, management fee growth, and sustainability progress. The group maintained an 8.0cps dividend amid a $1.4 billion diversified property portfolio and a strong balance sheet.

Godolphin Resources is spinning out its Narraburra Rare Earths Project into a new ASX-listed entity, Matrix Critical Minerals, with MST Financial appointed to spearhead the IPO expected in the second half of 2026.

WA1 Resources has significantly increased the indicated resource at its Luni Niobium Project to 93 Mt at 1.32% Nb2O5, backed by A$131 million in cash and progressing key development workstreams including permitting and metallurgical testwork.

US Masters Residential Property Group (URF) sold 40 properties for US$48.59 million in Q1 2026, cutting its portfolio to 121 assets valued at US$123.21 million. The Group targets a full exit by year-end amid stable market conditions despite geopolitical and local political challenges.

Amplia Therapeutics has launched a Phase 2b trial testing a new daily dosing regimen of narmafotinib combined with chemotherapy in advanced pancreatic cancer, aiming to accelerate progress towards a pivotal Phase 3 study.

Meridian Energy's April 2026 operating report highlights robust hydro inflows and retail sales growth while electricity futures prices continue to decline.

oOh!media posts solid early 2026 revenue growth and launches a $12 million annual savings program, while exiting retail media and navigating takeover bids.